BLACK DIAMOND THERAPEUTICS, INC. Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay of 6.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent · last filed 2026-08-05
- BLACK DIAMOND THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of employees' gross pay for the quarter ending 2026-03-31 was 6.00%, a 0.00% change year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of employees' gross pay for the quarter ending 2025-03-31 was 6.00%, a 0.00% change year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of employees' gross pay for the quarter ending 2024-03-31 was 6.00%, a 0.00% change year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of employees' gross pay for the quarter ending 2023-03-31 was 6.00%, a 0.00% change year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2025 was 6.00%, a 0.00% change from fiscal 2024.
- BLACK DIAMOND THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2024 was 6.00%, a 0.00% change from fiscal 2023.
- BLACK DIAMOND THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2023 was 6.00%, a 0.00% change from fiscal 2022.
- BLACK DIAMOND THERAPEUTICS, INC. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2022 was 6.00%, a 0.00% change from fiscal 2021.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 3 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 6 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 9 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 12 month |
|---|---|---|---|---|
| 2026-06-30 | 6.00% 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | 6.00% 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 6.00% 10-K · filed 2026-03-16 | |||
| 2025-09-30 | 6.00% 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 6.00% 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 6.00% 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | 6.00% 10-K · filed 2025-03-06 | |||
| 2024-09-30 | 6.00% 10-Q · filed 2024-11-05 | |||
| 2024-06-30 | 6.00% 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | 6.00% 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | 6.00% 10-K · filed 2024-03-12 | |||
| 2023-09-30 | 6.00% 10-Q · filed 2023-11-06 | |||
| 2023-06-30 | 6.00% 10-Q · filed 2023-08-11 | |||
| 2023-03-31 | 6.00% 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | 6.00% 10-K · filed 2023-03-09 | |||
| 2022-09-30 | 6.00% 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | 6.00% 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | 6.00% 10-Q · filed 2022-05-11 | |||
| 2021-12-31 | 6.00% 10-K · filed 2022-03-17 | |||
| 2021-09-30 | 6.00% 10-Q · filed 2021-11-08 | |||
| 2021-06-30 | 6.00% 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | 6.00% 10-Q · filed 2021-05-07 | |||
| 2020-12-31 | 6.00% 10-K · filed 2021-03-25 | |||
| 2020-09-30 | 6.00% 10-Q · filed 2020-11-10 | |||
| 2020-06-30 | 6.00% 10-Q · filed 2020-08-11 | |||
| 2020-03-31 | 6.00% 10-Q · filed 2020-05-12 | |||
| 2019-12-31 | 6.00% 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |